Thursday, 1 November 2018

FDA panel votes against Alkermes' depression treatment

An advisory panel to the U.S. Food and Drug Administration on Thursday voted against approving Alkermes Plc's experimental depression treatment.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)